Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations

Blood. 2008 Feb 15;111(4):2163-9. doi: 10.1182/blood-2007-08-104760. Epub 2007 Sep 13.

Abstract

Histone H2AX is required to maintain genomic stability in cells and to suppress malignant transformation of lymphocytes in mice. H2ax(-/-)p53(-/-) mice succumb predominantly to immature alphabeta T-cell lymphomas with translocations, deletions, and genomic amplifications that do not involve T-cell receptor (TCR). In addition, H2ax(-/-)p53(-/-) mice also develop at lower frequencies B and T lymphomas with antigen receptor locus translocations. V(D)J recombination is initiated through the programmed induction of DNA double-strand breaks (DSBs) by the RAG1/RAG2 endonuclease. Because promiscuous RAG1/RAG2 cutting outside of antigen receptor loci can promote genomic instability, H2ax(-/-)p53(-/-) T-lineage lymphomas might arise, at least in part, through erroneous V(D)J recombination. Here, we show that H2ax(-/-)p53(-/-)Rag2(-/-) mice exhibit a similar genetic predisposition as do H2ax(-/-)p53(-/-) mice to thymic lymphoma with translocations, deletions, and amplifications. We also found that H2ax(-/-)p53(-/-)Rag2(-/-) mice often develop thymic lymphomas with loss or deletion of the p53(+) locus. Our data show that aberrant V(D)J recombination is not required for rapid onset of H2ax/p53-deficient thymic lymphomas with genomic instability and that H2ax deficiency predisposes p53(-/-)Rag2(-/-) thymocytes to transformation associated with p53 inactivation. Thus, H2AX is essential for suppressing the transformation of developing thymocytes arising from the aberrant repair of spontaneous DSBs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • DNA-Binding Proteins / deficiency
  • DNA-Binding Proteins / genetics
  • Death
  • Genomic Instability / genetics
  • Histones / deficiency*
  • Histones / genetics
  • Infertility, Male / genetics
  • Lymphoma / genetics*
  • Lymphoma / mortality
  • Lymphoma / pathology
  • Male
  • Metaphase
  • Mice
  • Mice, Knockout
  • T-Lymphocytes / pathology
  • Thymus Neoplasms / genetics*
  • Thymus Neoplasms / mortality
  • Thymus Neoplasms / pathology
  • Translocation, Genetic*
  • Tumor Suppressor Protein p53 / deficiency*
  • Tumor Suppressor Protein p53 / genetics
  • VDJ Recombinases / genetics*

Substances

  • DNA-Binding Proteins
  • H2AX protein, mouse
  • Histones
  • Rag2 protein, mouse
  • Tumor Suppressor Protein p53
  • VDJ Recombinases